CD4 and rheumatoid arthritis: Results in the non-RA cohort were similar: surface RANKL production was significantly higher in CD4+CD28− T-cells compared to that in CD28+ T-cells [2.4% (0–32.1) vs. 1.3 (0–34.8), p = 0.023, Figure 2A].